A Phase 1b/2 trial of Belzupacap-sarotalocan

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 25 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Mar 2025 According to Aura Biosciences media release, company look forward to our virtual urologic oncology investor event, where we will outline the Phase 1b/2 trial to further evaluate bel-sar clinical activity and future development plans.
17 Mar 2025 New trial record
03 Mar 2025 According to Aura Biosciences media release, company will host a virtual urologic oncology investor event on Monday, March 24, 2025, at 4:30 pm Eastern Time featuring a bladder cancer program update, including the planned Phase 1b/2 trial expansion and future development plans.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com